These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2479408

  • 1. Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes.
    Merchav S, Nagler A, Fleischer-Kurtz G, Tatarsky I.
    Br J Haematol; 1989 Oct; 73(2):158-64. PubMed ID: 2479408
    [Abstract] [Full Text] [Related]

  • 2. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S, Wagemaker G, Souza LM, Tatarsky I.
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [Abstract] [Full Text] [Related]

  • 3. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B, Broeders L, Touw I, Löwenberg B.
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P.
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [Abstract] [Full Text] [Related]

  • 5. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B, Spier C, Baier M, Taetle R, Broudy VC, List AF.
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [Abstract] [Full Text] [Related]

  • 6. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C, Cazzola M, Bergamaschi G, Bernasconi P, Dezza L, Invernizzi R, Pedrazzoli P.
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [Abstract] [Full Text] [Related]

  • 7. In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
    Carlo-Stella C, Cazzola M, Bernasconi P, Bergamaschi G, Dezza L, Pedrazzoli P, Rosti V, Tomaselli S, Zappone E.
    Haematologica; 1989 May; 74(2):181-6. PubMed ID: 2501171
    [Abstract] [Full Text] [Related]

  • 8. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Mayani H, Baines P, Bowen DT, Jacobs A.
    Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
    [Abstract] [Full Text] [Related]

  • 9. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S.
    Haematologica; 1992 Jan; 77(2):142-5. PubMed ID: 1383105
    [Abstract] [Full Text] [Related]

  • 10. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
    Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T.
    Acta Haematol; 1993 Jan; 89(3):113-8. PubMed ID: 8362599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.
    Estrov Z, Kurzrock R, Talpaz M, Blake M, Gutterman JU.
    Ann Hematol; 1991 Dec; 63(6):297-301. PubMed ID: 1756190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 17. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 20. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
    Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH, Estrov Z.
    Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.